“…Several clinical studies have demonstrated the beneficial effects of VNS in patients with heart failure, including but not limited to a significant improvement in left ventricular ejection fraction (LVEF), left ventricular end-systolic volume (LVESV), New York Heart Association (NYHA) class, (De Ferrari et al, 2011;Premchand et al, 2014Premchand et al, , 2015 and autonomic balance by heart rate variability (Libbus, Nearing, Amurthur, KenKnight, & Verrier, 2016). VNS has a proven safety profile with low incidence of side effects and adverse events in the management of more than 100,000 patients with epilepsy or depression, (Conway, Colijn, & Schachter, 2015) and therefore promises to provide a reasonable device-based solution for treatment of symptomatic heart failure in the presence of guideline-directed medical therapy.…”